BRANMOOR
THURSDAY · 14 MAY 2026

Diligence Sheet

Healthcare due diligence.
Primary-source. Structured.

Per-entity diligence packages built from Medicare cost reports, 340B program data, utilization data, CMS quality metrics, and payer policy exposure. For healthcare PE, investment banking, M&A advisory, and healthcare law firms.

Per-sheet pricing. No subscription required.

What a Diligence Sheet contains

One structured package per target entity. Every data point linked to its primary source. Delivered as a PDF + structured JSON export.

Financial performance

  • Operating margin (3-year trend, vs. peer cohort)
  • Days cash on hand
  • Total revenue and payer mix breakdown
  • Cost per discharge by service line

Source: Medicare Hospital Cost Reports (CMS)

340B program status

  • 340B covered entity status and HRSA registration
  • Contract pharmacy network
  • HRSA audit history and findings

Source: HRSA 340B database, HRSA audit reports

Utilization and quality

  • Inpatient and outpatient volume by service line
  • CMS Care Compare quality ratings
  • Readmission rates vs. national benchmark

Source: CMS utilization files, Care Compare

Payer policy exposure

  • Revenue cycle risk from recent payer policy changes
  • PA burden index for top 10 service lines
  • Commercial rate spread vs. Medicare benchmark

Source: PayerPolicy Watch pipeline, ClearRate MRF data

Who uses Diligence Sheet

Healthcare PE & Growth Equity

Evaluate targets before LOI. Identify operational risk from payer policy exposure and 340B program status. Comparable to a 2-week analyst workstream in hours.

Healthcare Investment Banking

Revenue quality and payer mix analysis for deal preparation. Primary-source data with methodology — defensible in the data room.

Healthcare M&A Advisory & Law

Client deliverable for healthcare transaction diligence. Structured data export feeds your models. Primary-source documentation reduces diligence risk.

Sample Diligence Sheet

The sample below uses publicly available CMS cost report data for a composite entity. Actual sheets are generated for specific named targets from live pipeline data.

Sample sheet preview — coming at product launch.

Request a sample for your current deal →

Pricing

Enterprise

$60K–$120K ACV

Unlimited sheets. API access. Portfolio monitoring. Dedicated analyst support. Typical anchor: $90K ACV.

Contact sales

Enterprise ACV anchored at $90K for a named license covering one firm. Pricing holds — the first deal sets the floor.

Primary sources

SourceWhat it providesUpdate cadence
CMS Hospital Cost Reports Operating margin, payer mix, cost structure, bed count Annual (12–18 month lag)
HRSA 340B Database Covered entity status, contract pharmacy network, audits Monthly
CMS Care Compare Quality ratings, readmission rates, utilization Quarterly
CMS Price Transparency MRFs Contracted commercial rates vs. Medicare benchmark Annual (hospital-reported)
PayerPolicy Watch pipeline PA burden, formulary exposure, recent payer policy changes Weekly
Full methodology →